However, despite being the largest study in this field to date, covering more than 3.5 million pregnancies, relatively few women used these drugs, and some estimates were imprecise
Here's what you need to know: Medicare Coverage (Effective Mid-2026) Following the November 2025 Trump administration agreements, Medicare will cover GLP-1 medications for obesity with: $50 monthly copay for eligible patients $245 government cost (down from $1,000+ list prices) Medicare Eligibility Requirements: BMI over 27 with prediabetes OR established cardiovascular disease, OR BMI over 30 with uncontrolled hypertension, kidney disease, or heart failure, OR BMI over 35 (severe obesity) Medicaid Coverage States can opt into $245 monthly pricing for all covered uses
GLP-1 medications are complex peptide-based drugs that are expensive to manufacture, relatively new, and still under patent protection for brand-name versions
A patient may be a candidate for GLP-1 injections if they are struggling with weight loss, appetite control, overeating, cravings, obesity, or weight-related health concerns
Share Your Story MOAAs advocacy relies on the testimony and experiences of servicemembers and families impacted by changes to TRICARE policy